↓ Skip to main content

Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety

Overview of attention for article published in Journal of Translational Medicine, May 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
56 Mendeley